Form 4 for LUNG Pulmonx Corp
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-016021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | A - Grant | $0.00 | +78.9K | 259.9K | +44% | $0 |
| DM | 2023-03-03 | 2023-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | S - Sale | $11.03 | -1,206 | 181.8K | -0.7% | -$13.3K |
| D | 2023-03-03 | 2023-03-01 | LUNG | Rose Geoffrey Beran | Chief Commercial Off | A - Grant | $0.00 | +54.0K | 54.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | A | A | 78,900 | $0.00 | 259,893 | D | — | — | (F4) Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2023. |
| 2 | Common | Common Stock | 2023-03-01 | S | D | 769 | $11.03 | 180,993 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-01 | S | D | 437 | $11.03 | 181,762 | D | — | — | (F2) Includes 1,162 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on February 15, 2023. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2023-03-01 | A | A | 54,000 | $0.00 | 54,000 | D | $11.48 · — to 2033-02-28 | 54,000 Common Stock | (F5) The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2023. |